ORPHA:96178
Ring chromosome 16 syndrome
Also known as: Ring 16 · Ring chromosome 16
Publications
1,365
Trials
0
Interventional, condition-specific
Researchers
1,670
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare chromosomal anomaly syndrome, resulting from the partial deletion of chromosome 16, characterized by pre- and postnatal growth delay, severe , , speech delay, and craniofacial dysmorphism (e.g. microcephaly, hypertelorism, downslanted palpebral fissures, ptosis, telecantus, low set and ears, broad flat nasal bridge, down-turned mouth corners, high palate, retrognathia). Patients may also present cataract, mild synophrys, , and poor social contact. heart anomalies (e.g. ventricular septal defect, patent ductus arteriosus) have also been reported.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019909
- UMLS:C4706449
Additional Mondo synonyms (1)
Ring chromosome type 16
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,365 matched papers (860 in last 10 years) Source
- Phenotype characterisedPresent
19 HPO annotations (e.g. Autistic behavior; Talipes equinovarus; Delayed speech and language development) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
19
Associated phenotypes · MONDO:0019909
- Autistic behavior
- Talipes equinovarus
- Delayed speech and language development
- Intellectual disability
- Short philtrum
Showing 5 of 19 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,365
1,365 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,365 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
860 in the last 10 years · low confidence
Phrase hits: 1,365 · MeSH hits: 0
Who's working on it?
1,670
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Wegner HA25 papers · 2025
Institute of Organic Chemistry, Justus Liebig University Giessen, Heinrich-Buff-Ring 17, 35392 Giessen, Germany.
Papers in Europe PMC - 02Janek J15 papers · 2026
Institute of Physical Chemistry, Justus Liebig University Giessen, Heinrich-Buff-Ring 17, D-35392, Giessen, Germany. juergen.janek@pc.jlug.de.
Papers in Europe PMC - 03Chatterjee S12 papers · 2025
Institute of Experimental Physics I and Center for Materials Research (LaMa), Justus Liebig University Giessen, Heinrich-Buff-Ring 16, D-35392 Giessen, Germany.
Papers in Europe PMC - 04Becker J10 papers · 2025
Institute of Inorganic Chemistry, Justus Liebig University, Heinrich-Buff-Ring 17, 35392, Giessen, Germany.
Papers in Europe PMC - 05Dürr M10 papers · 2026
Institut für Angewandte Physik, Justus-Liebig-Universität Giessen, Heinrich-Buff-Ring 16, DE-35392 Giessen, Germany.
Papers in Europe PMC - 06Schreiner PR10 papers · 2025
Institute of Organic Chemistry, Justus Liebig University, Heinrich-Buff-Ring 17, 35392 Giessen, Germany.
Papers in Europe PMC - 07Smarsly BM10 papers · 2025
Institute of Physical Chemistry, Justus-Liebig-University, Heinrich-Buff-Ring 17, 35392 Giessen, Germany.
Papers in Europe PMC - 08Eckhardt JK9 papers · 2026
Institute of Physical Chemistry, Justus-Liebig-University Giessen, Heinrich-Buff-Ring 17, D-35392, Giessen, Germany.
Papers in Europe PMC - 09Elm MT9 papers · 2024
Center for Materials Research (LaMa), Justus Liebig University Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany.
Papers in Europe PMC - 10Henss A9 papers · 2025
I. Physikalisches Institut, Justus-Liebig-Universität Gießen, Heinrich-Buff-Ring 16, 35392, Gießen, Germany.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 40 · after dedupe 40 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 40 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (40)
- isrctn·ISRCTN82481391·No longer recruiting·A study in healthy participants to assess how the cannabidiol is absorbed into the blood, after inhalation via a new device that heats without burning the hemp
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN22165252·No longer recruiting·TinnSpire: Personalised vagus nerve & sound stimulation for the treatment of tinnitus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18283468·No longer recruiting·A clinical trial to learn more about the absorption of radiolabeled drug LXE408, how the body breaks it down, and how quickly the body gets rid of it in healthy men
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN33793580·Recruiting·18F-LW223: A new tool for detecting inflammation in the body
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16645843·Recruiting·Efficacy of CliMACT, a digital training for mental health promotion in youth with climate change-related distress
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17870921·No longer recruiting·Behavioural change for cancer prevention: A pilot study protocol of a digital intervention
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12166286·No longer recruiting·A study in healthy adults to compare the bioavailability of EPA + DHA from two microalgal sources to one fish source and placebo
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10774395·Recruiting·Silicone compared to polyvinyl chloride ring pessary in the treatment of vaginal prolapse
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14632228·Recruiting·Research study for people who have cerebral small vessel disease (cSVD, damaged small blood vessels in the brain) and a stroke, which may lead to impaired memory and thinking and then dementia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11396451·Enrolling by Invitation·Dietary approaches to the management of polycystic ovary syndrome trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10890272·Recruiting·Pelvic floor muscle exercises plus pessary for treatment of prolapse versus pelvic floor muscle exercises alone
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN99912974·Recruiting·Phase-locked brain stimulation for people with Parkinson's disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17198496·No longer recruiting·Effects of a liquid blend containing kava and kratom in healthy adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18264301·Recruiting·Relative Motion Extension - Orthosis use in treating Trigger finger (ReMEx-OT) in the adult population – A multi-centre, randomised, superiority trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN29801527·No longer recruiting·A study to characterize nicotine delivery of the JUUL2 electronic nicotine delivery system in adults as compared to a commercially available e-cigarette and combustible cigarette
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15140257·Stopped·Effect of Icosapent ethyl on inflammation in the vessel wall assessed by the Fat Attenuation Index Score (IRIS-FAI)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13878343·No longer recruiting·Investigating the effects and practicalities of delivering sleep strategy workshops in secondary schools
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN34837836·No longer recruiting·A study to characterize nicotine delivery of the JUUL2 electronic nicotine delivery system as compared to a commercially available e-cigarette and combustible cigarette
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16176441·No longer recruiting·A clinical study to evaluate the contents of exhaled breath after use of the JUUL2 electronic nicotine delivery system and conventional cigarettes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN56383373·No longer recruiting·Identification of the value of a novel test for the surveillance of women with precancerous lesions of the cervix who wish to avoid surgical treatment
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN27514808·No longer recruiting·A study investigating the effectiveness, safety and quality of life in participants with age related visual impairment (macular degeneration) who have switched to faricimab, under real world conditions in Germany
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17301762·No longer recruiting·Stages, progression, and recovery of eating disorders in youth
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN54249743·No longer recruiting·Feasibility of the implementation of an intensive upper-limb rehabilitation system (NeuroVirt) intervention for stroke survivors
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17973296·No longer recruiting·An early phase clinical study on the safety and potential for allergic reactions of a new vaccine to treat allergy to cats
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN60504239·No longer recruiting·Study on nicotine uptake in smokers using electronic nicotine delivery systems compared to combustible cigarette
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Ring chromosome 16 syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Ring chromosome 16 syndrome" OR "Ring 16" OR "Ring chromosome 16" OR "Ring chromosome type 16"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Ring chromosome 16 syndrome" OR "Ring 16" OR "Ring chromosome 16" OR "Ring chromosome type 16"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1365) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-27T04:57:34.361Z
